AngioDynamics Stock Price Patterns
| ANGO Stock | USD 10.99 0.21 1.95% |
Momentum
Buy Extended
Oversold | Overbought |
EPS Estimate Current Year -0.29 | EPS Estimate Next Year -0.11 | Wall Street Target Price 19.3333 | EPS Estimate Current Quarter -0.10 | Quarterly Revenue Growth 0.09 |
Hype-based context for AngioDynamics connects recent headlines with price response and peer activity. This sentiment summary combines AngioDynamics' options data with short interest context.
Short Interest Snapshot - AngioDynamics
Short interest changes for AngioDynamics can signal shifts in positioning. The data is presented as positioning context without directional guidance.
200 Day MA 10.875 | Short Percent 0.0439 | Short Ratio 3.17 | Shares Short Prior Month 2.1 M | 50 Day MA 11.0134 |
Hype and Price Pattern for AngioDynamics
Headline and social attention around AngioDynamics provide a sentiment layer for price context. Headline intensity is shown to frame short-term volatility context.
Correlation between sentiment and price for AngioDynamics can be reviewed as contextual information. The view helps organize attention cycles alongside price movement.
AngioDynamics Implied Volatility | 0.97 |
AngioDynamics' implied volatility reflects the market's expectation for price variability, not direction. The indicator is a neutral reference for expected variability.
This section maps attention patterns around AngioDynamics and relates them to recent price behavior.
AngioDynamics after-hype prediction price | $ 10.99 |
This sentiment layer is designed to be read with forecasting, technical, analyst, earnings, and momentum context.
Rule 16 for the current AngioDynamics contract - Risk Context
Using the Rule 16 heuristic, the current implied volatility suggests an average daily move of about 0.0606% for the 2026-04-17 options. The figure is a neutral volatility reference; near $ 10.99, it implies about $ 0.01 per day.
AngioDynamics | Build AI portfolio with AngioDynamics Stock |
Mean reversion in AngioDynamics' price occurs when temporary dislocations - caused by sentiment extremes, news events, or liquidity shocks - correct back toward the stock's historical fair value.
AngioDynamics After-Hype Price Density Analysis
Understanding AngioDynamics' probability distribution helps investors calibrate position size to their risk tolerance. The tails of the AngioDynamics distribution capture low-probability but high-impact outcomes that naive point estimates ignore.
Next price density |
| Expected price to next headline |
AngioDynamics Estimiated After-Hype Price Volatility
Using AngioDynamics' historical news impact data, we estimate the likely price corridor for the next trading session after a significant headline. AngioDynamics' after-hype downside and upside margins for the prediction period are 7.93 and 14.05, respectively. Note that past news reactions for AngioDynamics are not guaranteed to repeat, particularly in novel market environments.
Current Value
The after-hype framework applied to AngioDynamics assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
AngioDynamics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as AngioDynamics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading AngioDynamics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with AngioDynamics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.29 | 3.08 | 0.08 | 0.05 | 8 Events | 8 Events | In 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
10.99 | 10.99 | 0.00 |
|
AngioDynamics Hype Timeline
AngioDynamics is presently traded for 10.99. The company has historical hype elasticity of 0.08, and average elasticity to hype of competition of 0.05. AngioDynamics is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at -0.29%. %. The volatility of related hype on AngioDynamics is about 1878.05%, with the expected price after the next announcement by competition of 11.04. About 12.0% of the company shares are held by company insiders. The book value of AngioDynamics was presently reported as 4.24. The company has Price/Earnings To Growth (PEG) ratio of 1.41. AngioDynamics recorded a loss per share of 0.67. The company had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in 8 days. Use AngioDynamics Basic Forecasting Models to cross-verify projections for AngioDynamics. The models provide a structured reference point.AngioDynamics Related Hype Analysis
Understanding how AngioDynamics' direct competitors react to news events helps investors anticipate contagion effects and sector-wide sentiment shifts that may affect AngioDynamics's performance.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SNDA | Sonida Senior Living | -0.37 | 7 per month | 0.87 | 0.20 | 2.36 | -1.99 | 9.34 | |
| FULC | Fulcrum Therapeutics | 0.51 | 9 per month | 5.27 | 0.01 | 7.22 | -7.25 | 67.17 | |
| LAB | Standard Biotools | 0.01 | 9 per month | 0.00 | -0.11 | 7.10 | -6.12 | 27.04 | |
| VREX | Varex Imaging Corp | 0.1 | 6 per month | 0.00 | -0.0028 | 3.53 | -3.31 | 14.01 | |
| OCGN | Ocugen Inc | 0.06 | 9 per month | 4.89 | 0.13 | 7.43 | -7.47 | 32.50 | |
| RAPT | RAPT Therapeutics | -0.05 | 10 per month | 2.33 | 0.14 | 7.76 | -6.37 | 64.19 | |
| OMER | Omeros | 1.14 | 9 per month | 4.48 | 0.05 | 5.07 | -7.14 | 87.69 | |
| NMRA | Neumora Therapeutics | 0.28 | 8 per month | 3.24 | 0.12 | 10.98 | -6.22 | 34.13 | |
| SY | So Young International | 0.06 | 5 per month | 4.04 | 0.03 | 5.54 | -5.83 | 25.73 | |
| CGEM | Cullinan Oncology LLC | -0.1 | 9 per month | 3.26 | 0.14 | 7.68 | -5.55 | 26.70 |
AngioDynamics Additional Predictive Modules
Most predictive techniques to examine AngioDynamics price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for AngioDynamics using various technical indicators. When you analyze AngioDynamics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About AngioDynamics Sentiment
Sentiment analysis for AngioDynamics evaluates news tone, positioning, and narrative momentum. Positioning shifts can amplify volatility changes during regime transitions. AngioDynamics has market cap of 452.98 M, P/E of 7.9, ROE of -15.26%.
Unless otherwise specified, financial data for AngioDynamics is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Updates may occur throughout the day.
Pair Trading with AngioDynamics
Pair trading with AngioDynamics can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
Moving together with AngioDynamics Stock
| 0.76 | FEMY | Femasys | PairCorr |
| 0.76 | RVP | Retractable Technologies | PairCorr |
| 0.64 | IINN | Inspira Technologies Oxy | PairCorr |
Moving against AngioDynamics Stock
| 0.71 | JOB | GEE Group | PairCorr |
| 0.71 | SOUL | Soulpower Acquisition | PairCorr |
| 0.67 | HYMTF | Hyundai Motor | PairCorr |
| 0.59 | POCI | Precision Optics | PairCorr |
| 0.52 | FMX | Fomento Economico | PairCorr |
| 0.48 | CMHF | Community Heritage | PairCorr |
Using correlated positions as AngioDynamics substitutes during tax-loss harvesting allows investors to capture a tax benefit without disrupting portfolio allocation. The key is finding instruments that track AngioDynamics closely enough to maintain equivalent risk and return.
The correlation of AngioDynamics with other assets is a key diversification metric. Pairing AngioDynamics with uncorrelated or negatively correlated instruments can reduce overall portfolio volatility without necessarily reducing expected returns.
Correlation analysis and pair trading evaluation for AngioDynamics can be used to frame hedging context. The view can be extended across sectors or other related groups.More Resources for AngioDynamics Stock Analysis
A structured review of AngioDynamics often starts with core financial statements and trend context. Ratios and trend metrics help frame AngioDynamics' operating context. Key reports that frame AngioDynamics Stock are listed below:Use AngioDynamics Basic Forecasting Models to cross-verify projections for AngioDynamics. The models provide a structured reference point. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.Analysis related to AngioDynamics should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Earnings Share -0.67 | Revenue Per Share | Quarterly Revenue Growth 0.09 | Return On Assets | Return On Equity |
The market value of AngioDynamics is measured differently than book value, which reflects AngioDynamics accounting equity. AngioDynamics' market capitalization is 452.98 M. A P/B ratio of 2.52 indicates the market values AngioDynamics above its accounting book value. Enterprise value stands at 404.15 M. Intrinsic value is an analytical estimate of AngioDynamics' underlying worth that can differ from price and book value. Valuation methods help interpret those gaps.
Note that AngioDynamics' intrinsic value and market price are different measures derived from different inputs. For AngioDynamics, key inputs include a P/E ratio of 7.9, a P/B ratio of 2.52, a profit margin of -9.02%, ROE of -15.26%. Market price reflects the current exchange level formed by active bids and offers.